as 04-18-2025 1:38pm EST
Founded: | 1971 | Country: | United States |
Employees: | N/A | City: | BURLINGTON |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | $266.44 | AVG Volume (30 days): | 877.6K |
Analyst Decision: | Strong Buy | Number of Analysts: | 17 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 8.84 | EPS Growth: | 85.21 |
52 Week Low/High: | $191.97 - $258.59 | Next Earning Date: | 04-29-2025 |
Revenue: | $13,008,900,000 | Revenue Growth: | 6.97% |
Revenue Growth (this year): | 10.25% | Revenue Growth (next year): | 4.74% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ANDERSON KERRII B | LH | Director | Mar 5 '25 | Sell | $255.63 | 500 | $127,817.35 | 13,166 | |
Schechter Adam H | LH | President & CEO | Feb 11 '25 | Sell | $244.62 | 6,121 | $1,497,319.02 | 86,445 |
LH Breaking Stock News: Dive into LH Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
PR Newswire
10 days ago
Zacks
11 days ago
MedTech Dive
13 days ago
Morningstar Research
16 days ago
Investor's Business Daily
17 days ago
Zacks
17 days ago
StockStory
17 days ago
The information presented on this page, "LH Laboratory Corporation of America Holdings - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.